Beigene Ltd Ads (BGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
Want to compare other data? Select Fields| Symbol | BGNE | AMGN | GILD | VRTX | BIIB |
| Company | Beigene Ltd Ads | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 169.00 | 242.11 | 63.50 | 236.51 | 287.32 |
| High | 171.91 | 242.14 | 63.50 | 236.51 | 288.00 |
| Low | 167.53 | 239.27 | 62.57 | 232.82 | 284.90 |
| Last | 170.36 | 241.49 | 62.98 | 235.83 | 285.50 |
| Change | +2.51 | +0.99 | -0.22 | +0.33 | -0.64 |
| % Change | +1.50% | +0.41% | -0.35% | +0.14% | -0.22% |
| Volume | 350,700 | 2,582,800 | 13,457,600 | 1,599,300 | 1,765,100 |
| 20-Day Average Volume | 303,555 | 1,932,185 | 7,742,710 | 1,304,295 | 1,393,330 |
| Previous Close | 167.85 | 240.50 | 63.20 | 235.50 | 286.14 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 166.48 | 240.40 | 65.22 | 224.77 | 295.30 |
| 20-Day Raw Stochastic | 74.99% | 68.51% | 8.49% | 96.90% | 5.55% |
| 20-Day Relative Strength | 50.06% | 62.68% | 38.15% | 70.37% | 45.01% |
| Weighted Alpha | +9.20 | +28.30 | -8.80 | +33.50 | +0.60 |
| Today's Opinion | 56% Buy | 96% Buy | 40% Sell | 100% Buy | 56% Buy |
| Previous Opinion | 56% Buy | 96% Buy | 40% Sell | 100% Buy | 56% Buy |
| Last Month's Opinion | 56% Buy | 100% Buy | 40% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.52% since 01/10/20 | +1.36% since 01/10/20 | -3.15% since 01/10/20 | +3.01% since 01/10/20 | -3.71% since 01/10/20 |
| Low | 160.18 on 01/13/20 | 234.79 on 01/13/20 | 62.57 on 01/17/20 | 224.56 on 01/13/20 | 284.24 on 01/16/20 |
| High | 171.91 on 01/17/20 | 243.85 on 01/16/20 | 65.26 on 01/13/20 | 236.51 on 01/17/20 | 306.35 on 01/14/20 |
| 1-Month | |||||
| %Chg | +4.61% since 12/17/19 | -0.56% since 12/17/19 | -4.86% since 12/17/19 | +8.37% since 12/17/19 | -3.91% since 12/17/19 |
| Low | 158.34 on 01/08/20 | 234.79 on 01/13/20 | 62.57 on 01/17/20 | 214.55 on 01/03/20 | 284.24 on 01/16/20 |
| High | 174.37 on 12/20/19 | 244.57 on 12/20/19 | 67.40 on 12/23/19 | 236.51 on 01/17/20 | 306.94 on 12/26/19 |
| 3-Month | |||||
| %Chg | +27.83% since 10/17/19 | +18.63% since 10/17/19 | -3.45% since 10/17/19 | +32.70% since 10/17/19 | +26.55% since 10/17/19 |
| Low | 131.24 on 10/18/19 | 200.78 on 10/21/19 | 62.38 on 11/14/19 | 174.82 on 10/21/19 | 220.01 on 10/18/19 |
| High | 210.35 on 11/25/19 | 244.99 on 12/17/19 | 68.16 on 12/12/19 | 236.51 on 01/17/20 | 318.00 on 10/22/19 |
| 6-Month | |||||
| %Chg | +40.57% since 07/17/19 | +36.39% since 07/17/19 | -5.89% since 07/17/19 | +33.13% since 07/17/19 | +24.43% since 07/17/19 |
| Low | 114.41 on 10/10/19 | 173.12 on 07/26/19 | 60.89 on 10/03/19 | 165.23 on 10/02/19 | 215.77 on 09/04/19 |
| High | 210.35 on 11/25/19 | 244.99 on 12/17/19 | 68.40 on 07/29/19 | 236.51 on 01/17/20 | 318.00 on 10/22/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 10,404,224 | 143,489,504 | 79,678,896 | 60,643,684 | 51,516,192 |
| Shares Outstanding, K | 61,072 | 594,184 | 1,265,146 | 257,150 | 180,442 |
| Annual Sales | 198,220,000 | 23,747,000,000 | 22,127,000,000 | 3,047,600,000 | 13,452,900,000 |
| Annual Net Income | -673,770,000 | 8,394,000,000 | 5,455,000,000 | 2,096,900,000 | 4,430,700,000 |
| Last Quarter Sales | 50,140,000 | 5,737,000,000 | 5,604,000,000 | 949,830,000 | 3,600,100,000 |
| Last Quarter Net Income | -307,360,000 | 1,968,000,000 | -1,165,000,000 | 57,520,000 | 1,545,900,000 |
| 60-Month Beta | 1.10 | 1.11 | 1.11 | 1.47 | 1.09 |
| Per-Share Information | |||||
| Most Recent Earnings | -5.11 on 11/12/19 | 3.66 on 10/29/19 | 1.75 on 10/24/19 | 1.23 on 10/30/19 | 9.17 on 10/22/19 |
| Latest Earnings Date | 02/26/20 | 01/30/20 | 02/03/20 | 02/04/20 | 01/30/20 |
| Most Recent Dividend | N/A | 1.450 on 11/14/19 | 0.630 on 12/12/19 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 02/13/20 | 12/12/19 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.46 | 9.91 | 61.81 | 8.86 |
